Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com suggests buying IGL, Godrej Properties and Chambal Fertilisers.
Sudarshan Sukhani of s2analytics.com recommends buying Jet Airways, Interglobe Aviation, Amara Raja Batteries, Marico, Indiabulls Housing and Glenmark Pharma.
Mitessh Thakkar of miteshthacker.com recommends buying HDFC Bank, Lupin, Larsen & Toubro and Delta Corp.
Havells, Glenmark Pharma and Jubilant Food, among others, are being tracked by analysts on Wednesday.
Prakash Gaba of prakashgaba.com is of the view that one may look at Glenmark Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Motherson Sumi Systems, United Spirits and Ashok Leyland and can sell Kotak Mahindra Bank, Glenmark Pharma and Jubilant Foodworks.
Ruchit Jain of Angel Broking is of the view that one may sell Hindalco Industries with a target of Rs 229.
Ruchit Jain of Angel Broking is of the view that one may buy Cholamandalam Finance with a target of Rs 1333.
Form 483 observations for Baddi unit is concerning but observations are not indicating invalidation of high frequency of OOS tests that is a silver lining, the research house said.
Shahina Mukadam, Independent Market Expert is of the view that one may exit Granules India on rallies.
L&T, Godrej Consumer and Pharma, among others, are on investors’ radar on Wednesday.
Mitessh Thakkar 0f mitesshthakkar.com has a buy on Ajanta Pharma with a stop loss of Rs 1237, target of Rs 1360 and a buy on DLF with a stop loss of Rs 215, target of Rs 245.
In an interview to CNBC-TV18's Latha Venkatesh, Anuj Singhal, and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks and sectors.
Watch the interview of SP Tulsian of sptulsian.com with Anuj Singhal, Latha Venkatesh and Surabhi Upadhyay on CNBC-TV18. He shared his readings and outlook on Rajratan Global Wire stock.
Vedanta, Glenmark and Hindalco, among others, on the radar of investors on Friday.
Sameet Chavan of Angel Broking is of the view that one may buy Adani Power with a target of Rs 36.80.
Vijay Chopra of enochventures.com feels that Glenmark Pharma may test Rs 800-850.
CA Rudramurthy BV, Research head at Vachana Investments suggests buying Glenmark Pharma, Cipla and Union Bank of India.
The immediate resistance on Nifty is now placed at 10,400 odd levels which are needed to be taken out in the follow-up buying. The support levels have now shifted to 10300 - 10320 levels, says Mustafa Nadeem, CEO, Epic Research.
Glenmark Pharma, DLF, Hero Motocorp and Titagarh Wagons could give up to 28 percent return in the short term.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Colgate Palmolive, Dr Reddy’s Laboratories, Glenmark Pharma and Grasim Industries and can sell Pidilite Industries.
According to Ashwani Gujral of ashwanigujral.com, one may exit Glenmark Pharma.
Rajat Bose of rajatkbose.com is of the view that one may buy Glenmark Pharma.
Mitessh Thakkar of mitesshthakkar.com suggests buying Reliance Industries.
Sharmila Joshi of sharmilajoshi.com is of the view that is of the view that one may prefer Glenmark Pharma, Sun Pharmaceutical and Lupin.